Skip to main content
. 2014 Dec 26;6(5):3013–3032. doi: 10.18632/oncotarget.3072

Figure 2. PRMT7 is overexpressed in breast cancer cell lines.

Figure 2

Western blot analysis for PRMT7 expression in established breast cancer cell lines (A). Densitometry of the band intensity (indicated below) were determined from 4 independent experiments and normalized to GAPDH and non-tumourigenic breast cells, MCF10A. *p < 0.05, #p = 0.13. Immunocytochemistry for PRMT7 expression was assessed in MCF10A, MCF7, MDA-MB-231, BT549 and BT20 cells (B). No primary antibody (No Primary) was used as a negative control.